Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.79
+0.38 (5.93%)
At close: Oct 27, 2026, 4:00 PM EDT
6.79
0.00 (0.00%)
After-hours: Oct 27, 2026, 4:00 PM EDT

Precision BioSciences Revenue

Precision BioSciences had revenue of $45.06M in the twelve months ending June 30, 2026, up 3,472.96% year-over-year. In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%. That makes Precision BioSciences the 28,705th largest company in the world by revenue and 3,853rd in the United States.

Revenue (ttm)
$45.06M
Revenue Growth
+3,472.96%
P/S Ratio
4.02
Revenue / Employee
$672,463
Employees
67
Market Cap
187.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.